Atezolizumab 1200 mg in 20 ML Injection Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: Tecentriq

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

Gruppo Oncologico Italiano di Ricerca Clinica1
German Cancer Research Center1

Indications

Cancer2
Mesotheliomas Pleural1
Early-stage Breast Cancer1
Lung Cancer1
Breast Cancer1

Other2 trials

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)

Phase 3

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.